Name | Number of supported studies | Average coverage | |
---|---|---|---|
enteroendocrine cell | 5 studies | 53% ± 20% |
Insufficient scRNA-seq data for expression of INSM1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 91% | 619.23 | 2417 / 2642 | 93% | 20.88 | 655 / 705 |
pancreas | 83% | 166.72 | 273 / 328 | 54% | 13.66 | 96 / 178 |
adrenal gland | 30% | 203.09 | 77 / 258 | 64% | 229.41 | 148 / 230 |
stomach | 53% | 75.08 | 190 / 359 | 22% | 12.05 | 64 / 286 |
prostate | 2% | 2.29 | 6 / 245 | 64% | 7.02 | 319 / 502 |
intestine | 34% | 42.14 | 330 / 966 | 22% | 9.05 | 116 / 527 |
breast | 1% | 0.96 | 6 / 459 | 26% | 9.97 | 286 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 24% | 12.89 | 11 / 45 |
esophagus | 0% | 0.44 | 6 / 1445 | 16% | 9.18 | 30 / 183 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.65 | 4 / 29 |
lung | 0% | 0.39 | 2 / 578 | 11% | 6.08 | 131 / 1155 |
thymus | 3% | 4.03 | 18 / 653 | 5% | 1.12 | 31 / 605 |
uterus | 0% | 0 | 0 / 170 | 8% | 3.99 | 35 / 459 |
bladder | 0% | 0 | 0 / 21 | 7% | 4.13 | 33 / 504 |
skin | 2% | 2.98 | 39 / 1809 | 3% | 0.09 | 13 / 472 |
eye | 0% | 0 | 0 / 0 | 4% | 0.55 | 3 / 80 |
ovary | 0% | 0 | 0 / 180 | 2% | 0.23 | 9 / 430 |
liver | 0% | 0 | 0 / 226 | 2% | 0.16 | 8 / 406 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.08 | 12 / 901 |
adipose | 1% | 1.39 | 14 / 1204 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.44 | 1 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.32 | 3 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0003309 | Biological process | type B pancreatic cell differentiation |
GO_0010468 | Biological process | regulation of gene expression |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0008283 | Biological process | cell population proliferation |
GO_0042421 | Biological process | norepinephrine biosynthetic process |
GO_0003310 | Biological process | pancreatic A cell differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0061549 | Biological process | sympathetic ganglion development |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0030182 | Biological process | neuron differentiation |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_2000179 | Biological process | positive regulation of neural precursor cell proliferation |
GO_0061104 | Biological process | adrenal chromaffin cell differentiation |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0010564 | Biological process | regulation of cell cycle process |
GO_0003323 | Biological process | type B pancreatic cell development |
GO_0043254 | Biological process | regulation of protein-containing complex assembly |
GO_0060290 | Biological process | transdifferentiation |
GO_0003358 | Biological process | noradrenergic neuron development |
GO_0016477 | Biological process | cell migration |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0030332 | Molecular function | cyclin binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | INSM1 |
Protein name | Insulinoma-associated protein 1 (Zinc finger protein IA-1) |
Synonyms | IA1 |
Description | FUNCTION: Sequence-specific DNA-binding transcriptional regulator that plays a key role in neurogenesis and neuroendocrine cell differentiation during embryonic and/or fetal development. Binds to the consensus sequence 5'-[TG][TC][TC][TT][GA]GGG[CG]A-3' in target promoters. Acts as a transcriptional repressor of NEUROD1 and INS expression via its interaction with cyclin CCND1 in a cell cycle-independent manner. Negatively regulates skeletal muscle-specific gene expression in endocrine cells of the pituitary by inhibiting the Notch signaling pathway. Represses target gene transcription by recruiting chromatin-modifying factors, such as HDAC1, HDAC2, HDAC3, KDM1A and RCOR1 histone deacetylases. Binds to its own promoter, suggesting autoregulation as a self-control feedback mechanism. Competes with histone H3 for the same binding site on the histone demethylase complex formed by KDM1A and RCOR1, and thereby inhibits demethylation of histone H3 at 'Lys-4' . Promotes the generation and expansion of neuronal basal progenitor cells in the developing neocortex. Involved in the differentiation of endocrine cells of the developing anterior pituitary gland, of the pancreas and intestine, and of sympatho-adrenal cells in the peripheral nervous system. Promotes cell cycle signaling arrest and inhibition of cellular proliferation. . |
Accessions | Q01101 ENST00000310227.3 |